Pulmonary Arterial Hypertension

descriptionPublicationkeyboard_double_arrow_right Article 01 Jul 2018 English Publisher:Elsevier BVJournal:Heart Failure Clinics, volume 14, pages 255-269 (issn: 1551-7136,

Copyright policy )

Authors: Mark W, Dodson; Lynette M, Brown; Charles Gregory, Elliott;

doi: 10.1016/j.hfc.2018.02.003

pmid: 29966625

Pulmonary Arterial Hypertension

- Summary
- Subjects
- Metrics

Abstract

This article provides an overview of pulmonary arterial hypertension (PAH), beginning with the initial pathologic recognition of pulmonary hypertension more than 100 years ago and progressing to the current diagnostic categorization of PAH. It reviews the epidemiology, pathophysiology, genetics, and modern treatment of PAH. The article discusses several important recent studies that have highlighted the importance of new management strategies, including serial risk assessment and combination pharmacotherapy.

Related Organizations

Intermountain Medical Center
United States
Intermountain Healthcare
United States
University of Utah
United States

Keywords

Male, Survival Rate, Risk Factors, Hypertension, Pulmonary, Humans, Drug Therapy, Combination, Female, Molecular Targeted Therapy, Antihypertensive Agents

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	61
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 1%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 1%